Loss-of-function mutations in LRP5 cause osteoporosis-pseudoglioma syndrome (OPPG), a low bone mass disorder, with severe low BMD and pathological vascularization of the retina (19), while point mutations having a gain-of-function affect have been observed in individuals with high bone mass (20). The gene discussed is LRP5; the disease is osteoporosis-pseudoglioma syndrome.